Using AGN-190584 in Subjects Utilizing Single -Use Daily, Contact Lenses
NCT05624320
·
clinicaltrials.gov ↗
PHASE4
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
Lack of interest
Conditions
Presbyopia
Interventions
DRUG:
AGN-190584
Sponsor
Gordon Schanzlin New Vision
Collaborators
[object Object]